Comparability of Microbiome Diversity in Self- and Physician-Collected HPV-Positive and HPV-Negative Cervicovaginal Samples

Laura Asensio-Puig,Álvaro de Andrés-Pablo,Olfat Khannous-Lleiffe,Raquel Ibáñez,Amelia Acera,Silvia de Sanjosé,Toni Gabaldón,Laia Alemany,Laia Bruni,Miquel Àngel Pavón
DOI: https://doi.org/10.3390/ijms25115736
IF: 5.6
2024-05-25
International Journal of Molecular Sciences
Abstract:Recent studies have revealed the impact of human papillomavirus (HPV) infections on the cervicovaginal microbiome; however, few have explored the utility of self-collected specimens (SCS) for microbiome detection, obtained using standardised methods for HPV testing. Here, we present a proof-of-concept analysis utilising Oxford Nanopore sequencing of the 16S rRNA gene in paired samples collected either by the patient using an Evalyn Brush or collected by a physician using liquid-based cytology (LBC). We found no significant differences in the α-diversity estimates between the SCS and LBC samples. Similarly, when analysing β-diversity, we observed a close grouping of paired samples, indicating that both collection methods detected the same microbiome features. The identification of genera and Lactobacillus species in each sample allowed for their classification into community state types (CSTs). Notably, paired samples had the same CST, while HPV-positive and -negative samples belonged to distinct CSTs. As previously described in other studies, HPV-positive samples exhibited heightened bacterial diversity, reduced Lactobacillus abundance, and an increase in genera like Sneathia or Dialister. Altogether, this study showed comparable results between the SCS and LBC samples, underscoring the potential of self-sampling for analysing the microbiome composition in cervicovaginal samples initially collected for HPV testing in the context of cervical cancer screening.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to evaluate the comparability between self - collected specimens (SCS) and physician - collected specimens (LBC) in detecting the cervicovaginal microbiome. Specifically, the study aims to verify whether self - collected specimens can be used to analyze the composition of the cervicovaginal microbiome, especially in cervical cancer screening in the context of HPV testing, by comparing the microbial diversity (α - diversity and β - diversity) in the samples obtained by these two collection methods and their performance in distinguishing HPV - positive and - negative samples. ### Research Background - **High - risk human papillomavirus (HR - HPV) infection**: This is the main cause of the development of cervical cancer. Although most infections will resolve spontaneously, a small number of infections will progress to cervical intraepithelial neoplasia (CIN) or cancer. - **Cervical cancer screening**: In recent years, the promotion of organized screening programs and HPV vaccines has significantly reduced the incidence of cervical cancer in high - income countries. HPV testing, as the main method for cervical cancer screening, is more accurate and cost - effective than traditional cervical cytology (Pap smear). - **Self - sampling**: The safety and accessibility of self - sampling methods have increased women's enthusiasm for participating in screening, especially those women who may avoid having samples collected by physicians. ### Research Objectives - **Verify the effectiveness of the self - sampling method**: The study aims to compare the performance of self - sampling and physician - collected samples in detecting the cervicovaginal microbiome through 16S rRNA gene sequencing technology. - **Explore the impact of HPV infection on the microbiome**: The study also explores the differences in the microbiome between HPV - positive and - negative samples, especially the changes in the abundance of Lactobacillus bacteria and the increase in other specific genera. ### Main Findings - **α - diversity and β - diversity analysis**: The study found that there were no significant differences in α - diversity and β - diversity between self - sampling and physician - collected samples, indicating that the two methods are comparable in detecting microbiome characteristics. - **Differences between HPV - positive and - negative samples**: HPV - positive samples showed higher bacterial diversity, a decrease in the abundance of Lactobacillus bacteria, and an increase in the abundance of other genera such as Sneathia and Dialister. - **Community state types (CSTs) classification**: HPV - positive samples mainly belong to CST - III and CST - IV, while HPV - negative samples mainly belong to CST - I and CST - II. ### Conclusions - **Feasibility of self - sampling**: The study shows that the self - sampling method can be effectively used to detect the composition of the cervicovaginal microbiome, and its results are comparable to those of physician - collected samples. - **Future applications**: This finding provides a theoretical basis for using the self - sampling method for microbiome analysis in cervical cancer screening, which helps to improve the convenience and participation of screening. ### Methods - **Sample collection**: A total of 22 pairs of cervicovaginal samples were collected in the study, and each pair of samples included a self - sampling and a physician - collected sample. - **DNA extraction and sequencing**: DNA was extracted using the Maxwell® 16 LEV Blood DNA Kit, and the 16S rRNA gene was sequenced by Oxford Nanopore sequencing technology. - **Data analysis**: Classification was carried out using Kraken2, α - diversity and β - diversity analysis was carried out through Phyloseq, and CST classification was carried out using a random forest model. ### Significance - **Clinical applications**: The successful verification of the self - sampling method means that self - sampling samples can be used for microbiome analysis in cervical cancer screening, thereby reducing the need for repeated sampling and improving the efficiency and acceptability of screening. - **Further research**: Future research can expand the sample size and optimize the sequencing protocol to explore in more detail the relationship between specific microbiome compositions and cancer progression.